taxonomy (1)
protein (1)
source (5)
structure (8)
composition (91)
disease (4)
reference (6)
site (8)
peptide (16)
- Homo sapiens (Human)
Taxonomy
- Fibronectin / Homo sapiens P02751
Protein
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977)
- Mammary Gland (UBERON_0001911)
- Urine (UBERON_0001088)
- Fibroblast (CL_0000057)
Source
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 3507
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Fuc(a1-3)"
- N-Linked / Complex / NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Fuc(a1-3)"
Reported structure
- Hex:3 HexNAc:2 (avg mass : 910.8325 )
- Hex:3 HexNAc:2 dHex:1 (avg mass : 1056.9755 )
- Hex:3 HexNAc:3 (avg mass : 1114.0275 )
- Hex:3 HexNAc:3 dHex:1 (avg mass : 1260.1705 )
- Hex:3 HexNAc:4 (avg mass : 1317.2225 )
- Hex:3 HexNAc:4 NeuAc:1 (avg mass : 1608.4804 )
- Hex:3 HexNAc:4 NeuAc:2 (avg mass : 1899.7383 )
- Hex:3 HexNAc:4 dHex:1 (avg mass : 1463.3655 )
- Hex:3 HexNAc:5 dHex:1 (avg mass : 1666.5605 )
- Hex:3 HexNAc:6 dHex:1 (avg mass : 1869.7555 )
- Hex:3 HexNAc:6 dHex:2 (avg mass : 2015.8985 )
- Hex:3 HexNAc:6 dHex:2 NeuAc:1 (avg mass : 2307.1564 )
- Hex:3 HexNAc:7 (avg mass : 1926.8075 )
- Hex:3 HexNAc:7 dHex:1 (avg mass : 2072.9505 )
- Hex:3 HexNAc:8 (avg mass : 2130.0025 )
- Hex:4 HexNAc:3 (avg mass : 1276.1699 )
- Hex:4 HexNAc:3 NeuAc:1 (avg mass : 1567.4278 )
- Hex:4 HexNAc:3 dHex:1 (avg mass : 1422.3129 )
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 (avg mass : 1713.5708 )
- Hex:4 HexNAc:3 dHex:3
- Hex:4 HexNAc:4 (avg mass : 1479.3649 )
- Hex:4 HexNAc:4 NeuAc:1 (avg mass : 1770.6228 )
- Hex:4 HexNAc:4 dHex:1 (avg mass : 1625.5079 )
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 1916.7658 )
- Hex:4 HexNAc:4 dHex:2 (avg mass : 1771.6509 )
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2062.9088 )
- Hex:4 HexNAc:4 dHex:3 (avg mass : 1917.7939 )
- Hex:4 HexNAc:5 (avg mass : 1682.5599 )
- Hex:4 HexNAc:5 NeuAc:2 (avg mass : 2265.0757 )
- Hex:4 HexNAc:5 dHex:1 (avg mass : 1828.7029 )
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2119.9608 )
- Hex:4 HexNAc:5 dHex:3 (avg mass : 2120.9889 )
- Hex:4 HexNAc:6 (avg mass : 1885.7549 )
- Hex:4 HexNAc:6 NeuAc:2 (avg mass : 2468.2707 )
- Hex:4 HexNAc:6 dHex:1 (avg mass : 2031.8979 )
- Hex:4 HexNAc:6 dHex:2 (avg mass : 2178.0409 )
- Hex:4 HexNAc:7 dHex:1 (avg mass : 2235.0929 )
- Hex:5 HexNAc:2 (avg mass : 1235.1173 )
- Hex:5 HexNAc:3 (avg mass : 1438.3123 )
- Hex:5 HexNAc:3 NeuAc:1 (avg mass : 1729.5702 )
- Hex:5 HexNAc:3 dHex:1 (avg mass : 1584.4553 )
- Hex:5 HexNAc:3 dHex:2 (avg mass : 1730.5983 )
- Hex:5 HexNAc:4 (avg mass : 1641.5073 )
- Hex:5 HexNAc:4 NeuAc:1 (avg mass : 1932.7652 )
- Hex:5 HexNAc:4 NeuAc:2 (avg mass : 2224.0231 )
- Hex:5 HexNAc:4 dHex:1 (avg mass : 1787.6503 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2078.9082 )
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 (avg mass : 2370.1661 )
- Hex:5 HexNAc:4 dHex:2 (avg mass : 1933.7933 )
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 (avg mass : 2225.0512 )
- Hex:5 HexNAc:4 dHex:3 (avg mass : 2079.9363 )
- Hex:5 HexNAc:4 dHex:4
- Hex:5 HexNAc:5 (avg mass : 1844.7023 )
- Hex:5 HexNAc:5 dHex:1 (avg mass : 1990.8453 )
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2282.1032 )
- Hex:5 HexNAc:5 dHex:2 (avg mass : 2136.9883 )
- Hex:5 HexNAc:5 dHex:3 (avg mass : 2283.1313 )
- Hex:5 HexNAc:6 (avg mass : 2047.8973 )
- Hex:5 HexNAc:6 dHex:1 (avg mass : 2194.0403 )
- Hex:5 HexNAc:6 dHex:1 NeuAc:1 (avg mass : 2485.2982 )
- Hex:6 HexNAc:3 (avg mass : 1600.4547 )
- Hex:6 HexNAc:4 (avg mass : 1803.6497 )
- Hex:6 HexNAc:4 NeuAc:1 (avg mass : 2094.9076 )
- Hex:6 HexNAc:4 dHex:1 (avg mass : 1949.7927 )
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 (avg mass : 2241.0506 )
- Hex:6 HexNAc:4 dHex:2 (avg mass : 2095.9357 )
- Hex:6 HexNAc:4 dHex:3 (avg mass : 2242.0787 )
- Hex:6 HexNAc:5 (avg mass : 2006.8447 )
- Hex:6 HexNAc:5 NeuAc:1 (avg mass : 2298.1026 )
- Hex:6 HexNAc:5 NeuAc:3 (avg mass : 2880.6184 )
- Hex:6 HexNAc:5 dHex:1 (avg mass : 2152.9877 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:1 (avg mass : 2444.2456 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:2 (avg mass : 2735.5035 )
- Hex:6 HexNAc:5 dHex:1 NeuAc:3 (avg mass : 3026.7614 )
- Hex:6 HexNAc:5 dHex:2 (avg mass : 2299.1307 )
- Hex:6 HexNAc:5 dHex:3 (avg mass : 2445.2737 )
- Hex:6 HexNAc:5 dHex:3 NeuAc:1
- Hex:6 HexNAc:6 (avg mass : 2210.0397 )
- Hex:6 HexNAc:6 NeuAc:1 (avg mass : 2501.2976 )
- Hex:6 HexNAc:6 NeuAc:2 (avg mass : 2792.5555 )
- Hex:6 HexNAc:6 dHex:1 (avg mass : 2356.1827 )
- Hex:7 HexNAc:2 (avg mass : 1559.4021 )
- Hex:7 HexNAc:4 dHex:1 (avg mass : 2111.9351 )
- Hex:7 HexNAc:6 (avg mass : 2372.1821 )
- Hex:7 HexNAc:6 NeuAc:2 NeuGc:1 (avg mass : 3261.9552 )
- Hex:7 HexNAc:6 dHex:1 (avg mass : 2518.3251 )
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 (avg mass : 3100.8409 )
- Hex:7 HexNAc:7 dHex:4 (avg mass : 3159.9491 )
- Hex:8 HexNAc:2 (avg mass : 1721.5445 )
- Hex:9 HexNAc:2 (avg mass : 1883.6869 )
- Hex:12 HexNAc:2 (avg mass : 2370.1141 )
Composition
- Cancer, breast (DOID:1612)
- Cystic Fibrosis (DOID:1485)
- Esophageal cancer (DOID:5041)
- Prostate cancer (DOID:10283)
Disease
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Computational framework for identification of intact glycopeptides in complex samples (2014 - Mayampurath A, Yu CY, Song E, Balan J, Mechref Y, Tang H.) / Status : Reviewed
- Additional fucosyl residues on membrane glycoproteins but not a secreted glycoprotein from cystic fibrosis fibroblasts. (1990 - Wang YM, Hare TR, Won B, Stowell CP, Scanlin TF, Glick MC, Hård K, van Kuik JA, Vliegenthart JF) / Status : Reviewed
- Structural studies of the sugar chains of cold-insoluble globulin isolated from human plasma. (1980 - Takasaki S, Yamashita K, Suzuki K, Kobata A) / Status : Reviewed
Reference
- Fibronectin / Homo sapiens
Reported glycosite
- WTPINSSTIIGYR (13aa)
- WTPINSSTIIGYR (13aa)
- NYTDCTSEGRR (11aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGR (28aa)
- NYTDCTSEGR (10aa)
- RGGNSNGALCHFPFLYNNHNYTDCTSEGR (29aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- DQCIVDDITYNVNDTFHK (18aa)
- DQCIVDDITYNVNDTFHKR (19aa)
- VNDTFHK (7aa)
- GEWTCIAYSQLRDQCIVDDITYNVNDTFHK (30aa)
- RHEEGHMINCTCFGQGR (17aa)
- RHEEGHMLNCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
- IDAPTNIQFVNETDSTVIVR (20aa)
- LDAPTNLQFVNETDSTVLVR (20aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex (avg mass : 1641.5073)
- Cystic Fibrosis (DOID:1485)
- Additional fucosyl residues on membrane glycoproteins but not a secreted glycoprotein from cystic fibrosis fibroblasts. (1990 - Wang YM, Hare TR, Won B, Stowell CP, Scanlin TF, Glick MC, Hård K, van Kuik JA, Vliegenthart JF) / Status : Reviewed
- Structural studies of the sugar chains of cold-insoluble globulin isolated from human plasma. (1980 - Takasaki S, Yamashita K, Suzuki K, Kobata A) / Status : Reviewed
-
Fibronectin / Homo sapiens
- Undefined site
- Fibronectin / Homo sapiens
-
- N-Linked / Complex (avg mass : 1787.6503)
- Fibroblast (CL_0000057)
- Cystic Fibrosis (DOID:1485)
-
Fibronectin / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1932.7652)
- Blood Plasma (UBERON_0001969)
-
Fibronectin / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 1932.7652)
- Blood Plasma (UBERON_0001969)
- Esophageal cancer (DOID:5041)
- Fibronectin / Homo sapiens
- Fibronectin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2152.9877)
- Fibroblast (CL_0000057)
- Cystic Fibrosis (DOID:1485)
-
Fibronectin / Homo sapiens
- Undefined site
- Fibronectin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2224.0231)
- Blood Plasma (UBERON_0001969)
- Esophageal cancer (DOID:5041)
- Fibronectin / Homo sapiens
- Fibronectin / Homo sapiens
-
- N-Linked / Complex (avg mass : 2224.0231)
- Blood Plasma (UBERON_0001969)
-
Fibronectin / Homo sapiens
- Undefined site
-
- N-Linked / Complex (avg mass : 2299.1307)
- Fibroblast (CL_0000057)
- Cystic Fibrosis (DOID:1485)
-
Fibronectin / Homo sapiens
- Undefined site
- Fibronectin / Homo sapiens
-
- Hex:3 HexNAc:2 / N-Linked (avg mass : 910.8325)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:3 HexNAc:2 dHex:1 / N-Linked (avg mass : 1056.9755)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- GGNSNGAICHFPFIYNNHNYTDCTSEGR (28aa)
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:3 HexNAc:3 / N-Linked (avg mass : 1114.0275)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:3 HexNAc:3 dHex:1 / N-Linked (avg mass : 1260.1705)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:4 HexNAc:3 / N-Linked (avg mass : 1276.1699)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- RHEEGHMINCTCFGQGR (17aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
-
- Hex:3 HexNAc:4 / N-Linked (avg mass : 1317.2225)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:4 HexNAc:3 dHex:1 / N-Linked (avg mass : 1422.3129)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- GGNSNGAICHFPFIYNNHNYTDCTSEGR (28aa)
- NYTDCTSEGR (10aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:3 HexNAc:4 dHex:1 / N-Linked (avg mass : 1463.3655)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
-
- Hex:4 HexNAc:4 / N-Linked (avg mass : 1479.3649)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- RHEEGHMINCTCFGQGR (17aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
-
- Hex:7 HexNAc:2 / N-Linked (avg mass : 1559.4021)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGRR (11aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
-
- Hex:4 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1567.4278)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- RHEEGHMINCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
-
- Hex:3 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1608.4804)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:3 HexNAc:5 dHex:1 / N-Linked (avg mass : 1666.5605)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:3 dHex:1 NeuAc:1 / N-Linked (avg mass : 1713.5708)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- GGNSNGAICHFPFIYNNHNYTDCTSEGR (28aa)
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:4 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1770.6228)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- RHEEGHMINCTCFGQGR (17aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
-
- Hex:3 HexNAc:6 dHex:1 / N-Linked (avg mass : 1869.7555)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:3 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 1899.7383)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:3 HexNAc:7 / N-Linked (avg mass : 1926.8075)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGR (10aa)
-
- Hex:3 HexNAc:6 dHex:2 / N-Linked (avg mass : 2015.8985)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
-
- Hex:3 HexNAc:7 dHex:1 / N-Linked (avg mass : 2072.9505)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:3 HexNAc:8 / N-Linked (avg mass : 2130.0025)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:3 HexNAc:6 dHex:2 NeuAc:1 / N-Linked (avg mass : 2307.1564)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:12 HexNAc:2 / N-Linked (avg mass : 2370.1141)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- WTPINSSTIIGYR (13aa)
- WTPINSSTIIGYR (13aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGR (28aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
- IDAPTNIQFVNETDSTVIVR (20aa)
-
- Hex:4 HexNAc:3 dHex:3 / N-Linked
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:2 / N-Linked (avg mass : 1235.1173)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
-
- Hex:5 HexNAc:3 / N-Linked (avg mass : 1438.3123)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:5 HexNAc:3 dHex:1 / N-Linked (avg mass : 1584.4553)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:6 HexNAc:3 / N-Linked (avg mass : 1600.4547)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGR (10aa)
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:4 HexNAc:4 dHex:1 / N-Linked (avg mass : 1625.5079)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- GGNSNGAICHFPFIYNNHNYTDCTSEGR (28aa)
- NYTDCTSEGR (10aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
-
- Hex:5 HexNAc:4 / N-Linked (avg mass : 1641.5073)
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Fibronectin / Homo sapiens
- GGNSNGAICHFPFIYNNHNYTDCTSEGR (28aa)
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
-
- Hex:4 HexNAc:5 / N-Linked (avg mass : 1682.5599)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:5 HexNAc:4 dHex:1 / N-Linked (avg mass : 1787.6503)
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- WTPINSSTIIGYR (13aa)
- WTPINSSTIIGYR (13aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGR (28aa)
- NYTDCTSEGR (10aa)
- RGGNSNGALCHFPFLYNNHNYTDCTSEGR (29aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- DQCIVDDITYNVNDTFHK (18aa)
- GEWTCIAYSQLRDQCIVDDITYNVNDTFHK (30aa)
- RHEEGHMINCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
- IDAPTNIQFVNETDSTVIVR (20aa)
-
- Hex:6 HexNAc:4 / N-Linked (avg mass : 1803.6497)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:5 HexNAc:5 / N-Linked (avg mass : 1844.7023)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:4 dHex:2 / N-Linked (avg mass : 1933.7933)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
-
- Hex:6 HexNAc:4 dHex:1 / N-Linked (avg mass : 1949.7927)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
-
- Hex:5 HexNAc:5 dHex:1 / N-Linked (avg mass : 1990.8453)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:6 HexNAc:5 / N-Linked (avg mass : 2006.8447)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:6 / N-Linked (avg mass : 2047.8973)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- WTPINSSTIIGYR (13aa)
- WTPINSSTIIGYR (13aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2078.9082)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- WTPINSSTIIGYR (13aa)
- WTPINSSTIIGYR (13aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGR (28aa)
- NYTDCTSEGR (10aa)
- RGGNSNGALCHFPFLYNNHNYTDCTSEGR (29aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- DQCIVDDITYNVNDTFHK (18aa)
- DQCIVDDITYNVNDTFHKR (19aa)
- RHEEGHMINCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
- IDAPTNIQFVNETDSTVIVR (20aa)
-
- Hex:5 HexNAc:4 dHex:3 / N-Linked (avg mass : 2079.9363)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
-
- Hex:6 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 2094.9076)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- WTPINSSTIIGYR (13aa)
- WTPINSSTIIGYR (13aa)
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
- IDAPTNIQFVNETDSTVIVR (20aa)
-
- Hex:6 HexNAc:4 dHex:2 / N-Linked (avg mass : 2095.9357)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- WTPINSSTIIGYR (13aa)
- WTPINSSTIIGYR (13aa)
- NYTDCTSEGRR (11aa)
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
- IDAPTNIQFVNETDSTVIVR (20aa)
-
- Hex:5 HexNAc:5 dHex:2 / N-Linked (avg mass : 2136.9883)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGR (10aa)
-
- Hex:5 HexNAc:6 dHex:1 / N-Linked (avg mass : 2194.0403)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
-
- Hex:5 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2225.0512)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Fibronectin / Homo sapiens
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 2241.0506)
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- WTPINSSTIIGYR (13aa)
- WTPINSSTIIGYR (13aa)
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- HEEGHMLNCTCFGQGR (16aa)
- IDAPTNIQFVNETDSTVIVR (20aa)
- LDAPTNLQFVNETDSTVLVR (20aa)
-
- Hex:6 HexNAc:4 dHex:3 / N-Linked (avg mass : 2242.0787)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
-
- Hex:5 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2282.1032)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:4 dHex:1 NeuAc:2 / N-Linked (avg mass : 2370.1661)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
- IDAPTNIQFVNETDSTVIVR (20aa)
-
- Hex:5 HexNAc:4 dHex:4 / N-Linked
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:8 HexNAc:2 / N-Linked (avg mass : 1721.5445)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
-
- Hex:5 HexNAc:3 NeuAc:1 / N-Linked (avg mass : 1729.5702)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:5 HexNAc:3 dHex:2 / N-Linked (avg mass : 1730.5983)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:4 HexNAc:4 dHex:2 / N-Linked (avg mass : 1771.6509)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:5 dHex:1 / N-Linked (avg mass : 1828.7029)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- GGNSNGAICHFPFIYNNHNYTDCTSEGR (28aa)
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:9 HexNAc:2 / N-Linked (avg mass : 1883.6869)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- GGNSNGAICHFPFIYNNHNYTDCTSEGR (28aa)
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:4 HexNAc:6 / N-Linked (avg mass : 1885.7549)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:4 dHex:1 NeuAc:1 / N-Linked (avg mass : 1916.7658)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGR (10aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:4 dHex:3 / N-Linked (avg mass : 1917.7939)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:4 NeuAc:1 / N-Linked (avg mass : 1932.7652)
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / Structure 3507
- Cancer, breast (DOID:1612)
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- GGNSNGAICHFPFIYNNHNYTDCTSEGR (28aa)
- NYTDCTSEGR (10aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
- IDAPTNIQFVNETDSTVIVR (20aa)
- LDAPTNLQFVNETDSTVLVR (20aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
-
- Hex:4 HexNAc:6 dHex:1 / N-Linked (avg mass : 2031.8979)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:4 dHex:2 NeuAc:1 / N-Linked (avg mass : 2062.9088)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:7 HexNAc:4 dHex:1 / N-Linked (avg mass : 2111.9351)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:4 HexNAc:5 dHex:1 NeuAc:1 / N-Linked (avg mass : 2119.9608)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:5 dHex:3 / N-Linked (avg mass : 2120.9889)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:5 dHex:1 / N-Linked (avg mass : 2152.9877)
- Mammary Gland (UBERON_0001911)
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Fuc(a1-3)"
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
- RHEEGHMINCTCFGQGR (17aa)
-
- Hex:4 HexNAc:6 dHex:2 / N-Linked (avg mass : 2178.0409)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:6 HexNAc:6 / N-Linked (avg mass : 2210.0397)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- NYTDCTSEGRR (11aa)
- NYTDCTSEGR (10aa)
- DQCIVDDITYNVNDTFHK (18aa)
- VNDTFHK (7aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
-
- Hex:5 HexNAc:4 NeuAc:2 / N-Linked (avg mass : 2224.0231)
- N-Linked / Complex / NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-3)[NeuAc(?2-?)Gal(?1-?)GlcNAc(?1-?)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- N-Linked / Complex / NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-3)[NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-2)Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- GGNSNGAICHFPFIYNNHNYTDCTSEGR (28aa)
- GGNSNGAICHFPFIYNNHNYTDCTSEGRR (29aa)
- DQCIVDDITYNVNDTFHK (18aa)
- DQCIVDDITYNVNDTFHKR (19aa)
- RHEEGHMINCTCFGQGR (17aa)
- RHEEGHMLNCTCFGQGR (17aa)
- HEEGHMLNCTCFGQGR (16aa)
- IDAPTNIQFVNETDSTVIVR (20aa)
- LDAPTNLQFVNETDSTVLVR (20aa)
- ITTTPTNGQQGNSIEEVVHADQSSCTFDNISPGIEYNVSVYTVK (44aa)
-
- Hex:4 HexNAc:7 dHex:1 / N-Linked (avg mass : 2235.0929)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:4 HexNAc:5 NeuAc:2 / N-Linked (avg mass : 2265.0757)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
- Fibronectin / Homo sapiens
- DQCIVDDITYNVNDTFHK (18aa)
-
- Hex:5 HexNAc:5 dHex:3 / N-Linked (avg mass : 2283.1313)
- Mammary Gland (UBERON_0001911)
- Cancer, breast (DOID:1612)
-
Fibronectin / Homo sapiens
Source
Suggested structure
Disease
Reported glycosite
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Mass spectrometry observed peptide
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Reference
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Suggested structure
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Suggested structure
Disease
Reported glycosite
Mass spectrometry observed peptide
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Suggested glycosite
Source
Disease
Reported glycosite
Source
Disease
Reported glycosite
Disease
Reference
Reported glycosite
Suggested glycosite